BioStorage Technologies Introduces Rapid-Response Programs to Meet Market Demand for Emergency Biorepository Storage & Transition.

INDIANAPOLIS -- New Programs Provide Proactive Strategies for Protecting Stored Biomaterials in Anticipation of Environmental Disasters, Power Outages & Terrorist Attacks

Due to increased customer demand for disaster-preparedness and disaster-recovery services in the wake of recent global crises, BioStorage Technologies, Inc., the premier provider of advanced biomaterials storage, inventory management and worldwide cold chain logistics, has announced two new rapid-response programs. The Emergency Relocation and Transition Management programs - both of which build upon the company's established core storage and logistics services - provide life science organizations with strategies for maintaining the integrity of valuable stored biomaterials in the face of emergencies.

"It won't happen to us" is becoming an outdated adage in a world that has witnessed disasters of unprecedented scale and frequency. Recent events such as the hurricanes that devastated Florida, Georgia, Alabama, South Carolina and North Carolina; the August 2003 blackout that interrupted power to more than 50 million consumers and businesses in the U.S. and Canada; and other global crises are prompting strategic-thinking businesses to seek out BioStorage Technologies (BST) to deliver plans for protecting their valuable biomaterial assets.

The company's Emergency Relocation program is designed for businesses that need immediate, short-term, off-site storage in the aftermath of a crisis. BST's Transition Management program protects the integrity of samples being moved from one or more locations to a central repository.

These rapid-response programs feature:

--Immediately available climate-controlled storage space in BST's 22,500 square-foot facility

--Storage temperature options that include 2 - 8 degrees C, -20 degrees C, -70 degrees C and -190 degrees C

--Aggressive pricing, flexible contract terms and first month fees waived

--Expert logistics planning, regulatory-compliant packaging and environmental shipping

--End-to-end supervision, documentation, shipping clearance and audit trails to transition biomaterials quickly and safely to BST's storage facility

--Sample tracking using proprietary inventory management software

"Truly forward-thinking leaders realize that it's not a matter of 'if' but 'when' a crisis will occur," said F. John Mills, M.D., PhD., Chief Executive Officer and Chairman of BioStorage Technologies. "We have been piloting our rapid response programs for several months. These programs represent, in effect, a condensed delivery model of our existing services, enabling us to respond much more quickly to companies in crisis. We have reduced the average relocation time from weeks to days and have allocated 10% of our facility to emergency storage needs. With these programs, we can provide our customers with strategic plans for anticipating and responding to crises, ensuring fiscal and regulatory accountability."

Emergencies that threaten the physical integrity of storage facilities pose a unique threat for pharmaceutical, biotech, research, forensics and other regulated industries that need to store, freeze, track and maintain biological samples for long periods of time in highly sensitive and specialized conditions. Because these materials are often the basis for product development, research initiatives and donor programs, power outages or facility damage that compromise samples can be devastating. For example, a pharmaceutical company could jeopardize FDA approval and potentially lose millions of dollars in revenue if samples or specimens from the research, development and clinical trials of a single drug were damaged.

BioStorage Technologies provides cost-effective solutions that help businesses mitigate risk and accelerate availability of biospecimens by storing critical biomaterials in a secure, climate-controlled and regulatory-compliant environment. The company helps businesses store, manage and track biomaterials without the investment in the capital improvements required to maintain, monitor and update their own facilities.

About BioStorage Technologies, Inc.

BioStorage Technologies, Inc. (BST) is a premier provider of advanced biomaterials storage, inventory management and worldwide cold chain logistics. The company offers expert storage and management of a wide range of specimens and sample types, from fixed tissue preparations and cord blood to active pharmaceutical ingredients, donor materials, stem cells, plasma, serum and body fluids. BST serves pharmaceutical and biotechnology developers and manufacturers; non-profit and corporate clinical research facilities; donor organizations; tissue, bone and blood banks; forensic laboratories; universities; zoological and veterinarian treatment and research facilities; and healthcare and life sciences firms around the world.

The life science company's core differentiators include an industry-experienced leadership team; a 22,500 square-foot custom-built biorepository facility; advanced biological storage processes and technologies; and a proprietary inventory management system (ISISS(TM)) designed specifically for compliant biomaterial storage, tracking and reporting. BioStorage Technologies, Inc. is privately-held and headquartered in Indianapolis, Ind. For more information about the company, please visit www.biostoragetech.com or call [phone].